in vivo News and Research

RSS

Spicing up rheumatic disease treatment: Study explores role of herbs and spices in improving patients' condition

Research explores the potential benefits of herbs and spices in rheumatic diseases, highlighting their bioactive compounds and medicinal properties. It provides an updated review of their mechanisms of action and summarizes human studies in Rheumatoid Arthritis, Osteoarthritis, and Fibromyalgia.

4 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

Korean researchers develop hydrogel that could revolutionize treatment for female infertility

The Health Insurance Review & Assessment Service revealed that over the last year, more than 370,000 Koreans sought medical help for infertility or difficulties in conceiving.

3 Jul 2023

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine.

3 Jul 2023

WHO to declare artificial sweetener aspartame as possible carcinogen

The World Health Organization recently indicated that aspartame will likely be declared a “possible carcinogen to humans.”

29 Jun 2023

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis.

28 Jun 2023

Novel drug combination shows promise in treating pancreatic cancer

Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is mutated to be permanently "on," driving cells to excessively multiply and form tumors.

28 Jun 2023

New radionuclide-based agent offers hope for treating a variety of cancers

A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a novel theranostics approach.

27 Jun 2023

Novel biomaterials approach reveals how mechanical forces shape T cell fate

The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way.

26 Jun 2023

Study reveals neural circuits underlying adolescent stress-induced postpartum social behavior

Stress during adolescence can cause postpartum behavioral changes in women and other mammals, including depression and changes in social behavior after the birth of a child.

23 Jun 2023

BU researcher receives $2.8M grant to study serotonin's role in chronic stress and depression

Michael Wallace, PhD, assistant professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, was awarded a $2.8 million from the National Institutes of Health, National Institute of Mental Health.

23 Jun 2023

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Study describes the use of engineered commensal bacteria to increase antitumor immunity.

23 Jun 2023

Vegetarian diet linked to increased risk of varicose veins in men

Varicose veins (VVs) pose a significant medical burden, particularly among women. This study investigates the association between vegetarian and non-vegetarian diets and the risk of VVs in both genders.

20 Jun 2023

The contribution of transcription factor ROB1 to the pathophysiology of C. albicans-induced candidal infections

Researchers evaluated the function of the zinc finger transcription factor ROB1 and its two phenotypically distinct alleles in the pathogenesis of Candida albicans infections.

20 Jun 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

in vivo News and Research

Spicing up rheumatic disease treatment: Study explores role of herbs and spices in improving patients' condition

A novel RSV vaccine that could be effective across all ages

Korean researchers develop hydrogel that could revolutionize treatment for female infertility

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

WHO to declare artificial sweetener aspartame as possible carcinogen

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

Novel drug combination shows promise in treating pancreatic cancer

New radionuclide-based agent offers hope for treating a variety of cancers

Novel biomaterials approach reveals how mechanical forces shape T cell fate

Study reveals neural circuits underlying adolescent stress-induced postpartum social behavior

BU researcher receives $2.8M grant to study serotonin's role in chronic stress and depression

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Vegetarian diet linked to increased risk of varicose veins in men

The contribution of transcription factor ROB1 to the pathophysiology of C. albicans-induced candidal infections

Battle against RSV: Computational design paves way for new polyvalent vaccine

New mapping by Human Brain Project advances the understanding of neuroreceptor organization

ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery

Study provides a promising strategy for the treatment of neuroblastoma

Neurodevelopmental disruptions could pave the way for Alzheimer's disease

Research explores complex relationship between cholesterol and breast cancer risk

eBook: Using iPSCs models for human disease research and drug discovery eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News